Biotech / Pharma
AdvanCell
Biotech / Pharma
[subscription] AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, received a $315 million Series D led by Ally Bridge Group and Alpha Wave.. AdvanCell. Fwd: Stripe and Advent's lowball bid
Founded
Region